Compound Detail
CHEMBL55379
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL55379 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | HCZZACRTGWSLPL-UHFFFAOYSA-N |
7
Targets
7
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
402.4
MW (Da)
5.61
ALogP
4
HBA
2
HBD
62.8
PSA (Ų)
0.41
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 7 meas. best 6.54
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Protein kinase C alpha type CHEMBL299 | IC50 | 6.54 | 6.54 | 290.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 6.43 | 6.43 | 370.0 | 1 |
| Bcr/Abl fusion protein CHEMBL2096618 | IC50 | 6.43 | 6.43 | 371.5 | 1 |
| Protein kinase C delta type CHEMBL2996 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | IC50 | 5.75 | 5.75 | 1800.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| cAMP-dependent protein kinase (PKA) CHEMBL2094138 | IC50 | 4.14 | 4.14 | 73000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Protein kinase C alpha type | IC50 | = | 290.0 | nM | 6.54 | Inhibition of protein kinase C alpha. | - |
| Tyrosine-protein kinase ABL1 | IC50 | = | 370.0 | nM | 6.43 | Inhibition of v-Abl tyrosine kinase. | - |
| Bcr/Abl fusion protein | IC50 | = | 371.54 | nM | 6.43 | Inhibition of BCR-ABL kinase (unknown origin) | 23473682 |
| Protein kinase C delta type | IC50 | = | 1400.0 | nM | 5.85 | Inhibition of protein kinase C delta. | - |
| Epidermal growth factor receptor | IC50 | = | 1800.0 | nM | 5.75 | Inhibition of the epidermal growth factor receptor. | - |
| Proto-oncogene tyrosine-protein kinase Src | IC50 | = | 2200.0 | nM | 5.66 | Inhibition of c-Src-tyrosine kinase. | - |
| cAMP-dependent protein kinase (PKA) | IC50 | = | 73000.0 | nM | 4.14 | Inhibition of protein kinase A. | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.1016/S0960-894X(96)00601-4 | Tyrosine-protein kinase ABL1 | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Epidermal growth factor receptor | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Platelet-derived growth factor receptor | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | cAMP-dependent protein kinase (PKA) | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Protein kinase C alpha type | 1 |
| - | 10.1016/S0960-894X(96)00601-4 | Protein kinase C delta type | 1 |
| 23473682 | 10.1016/j.bmcl.2013.01.113 | Bcr/Abl fusion protein | 1 |
Data from ChEMBL 36 via Core Engine